- Report
- October 2024
- 196 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- February 2025
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- May 2024
- 132 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Clinical Trials
- April 2024
- 115 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- December 2024
- 200 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- June 2024
- 162 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- August 2024
- 63 Pages
Global
From €3336EUR$3,495USD£2,795GBP
- Report
- April 2018
- 80 Pages
Global
From €3149EUR$3,300USD£2,639GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- August 2022
United States
From €1851EUR$1,940USD£1,551GBP
- Report
- August 2022
Global
From €754EUR$790USD£632GBP
- Report
- February 2021
Global
From €2825EUR$2,960USD£2,367GBP
- Report
- October 2022
- 25 Pages
Global
€11691EUR$12,250USD£9,796GBP
- Report
- September 2024
- 85 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- August 2024
- 101 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- June 2022
- 122 Pages
Global
From €1909EUR$2,000USD£1,599GBP
The Celiac Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for celiac disease. Celiac disease is an autoimmune disorder that affects the digestive system, and is triggered by the ingestion of gluten. Celiac Drugs are designed to reduce the symptoms of the disease, such as abdominal pain, bloating, and diarrhea. These drugs can also help to reduce the risk of long-term complications, such as malnutrition and anemia.
Celiac Drugs are typically administered orally, and may include enzyme supplements, probiotics, and other medications. In some cases, a gluten-free diet may be recommended in conjunction with drug therapy.
Companies in the Celiac Drug market include AbbVie, Allergan, GlaxoSmithKline, Novartis, and Takeda. Show Less Read more
